title: Activated protein C: do more survive?
authors.affiliation: Consultant in Anaesthesia and Intensive Care, Queen Margaret Hospital, Whitefield Road, Dunfermline, Scotland, KY12 0SU, UK. alasdair.mackenzie@faht.scot.nhs.uk
authors.forename: Alasdair F
authors.initials: AF
authors.lastname: Mackenzie
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011486:Protein C / Q000009:adverse effects / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012449:Safety; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate
chemical_list: D000890:Anti-Infective Agents; D011486:Protein C; D011994:Recombinant Proteins; C421124:drotrecogin alfa activated